US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.3900
  • -0.0100-0.71%
Close Nov 6 16:00 ET
  • 1.3900
  • 0.00000.00%
Post 20:01 ET
255.87MMarket Cap-1544P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nektar Therapeutics Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
18.28M
-24.29%
EPS
-0.21
+12.13%
Analyst Rating
Buy

Nov 4, 2024

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 17.869M --
Nov 7, 2024 2024/Q3 -- / 18.280M --
Aug 8, 2024 2024/Q2 23.489M / 17.545M --
May 9, 2024 2024/Q1 21.639M / 15.342M --
Mar 4, 2024 2023/Q4 23.885M / 21.368M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 17.869M--
Nov 7, 20242024/Q3-- / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

  • Nektar Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 10 02:07

  • Nektar Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 11 02:13

  • Nektar Therapeutics | 10-K: FY2023 Annual Report

    Mar 6 06:16

  • Nektar Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 06:54

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data